共查询到20条相似文献,搜索用时 15 毫秒
1.
衣霉素属于核苷类抗生素,具有抑制蛋白质N-糖基化的活性,是潜在的药物先导化合物.罗中链霉菌(Streptomyces luozzhongensis)TRM49605是一株产衣霉素的链霉菌属(Streptomyces)的新物种.本研究旨在探索TRM49605中衣霉素生物合成基因簇的生物学功能,为新型药物开发提供理论依据.... 相似文献
2.
Masumi Izawa Takashi Kawasaki Yoichi Hayakawa 《Applied and environmental microbiology》2013,79(22):7110-7113
Thioviridamide is a unique peptide antibiotic containing five thioamide bonds from Streptomyces olivoviridis. Draft genome sequencing revealed a gene (the tvaA gene) encoding the thioviridamide precursor peptide. The thioviridamide biosynthesis gene cluster was identified by heterologous production of thioviridamide in Streptomyces lividans. 相似文献
3.
Jean Franco Castro Valeria Razmilic Juan Pablo Gomez-Escribano Barbara Andrews Juan A. Asenjo Mervyn J. Bibb 《Applied and environmental microbiology》2015,81(17):5820-5831
Streptomyces leeuwenhoekii, isolated from the hyperarid Atacama Desert, produces the new ansamycin-like compounds chaxamycins A to D, which possess potent antibacterial activity and moderate antiproliferative activity. We report the development of genetic tools to manipulate S. leeuwenhoekii and the identification and partial characterization of the 80.2-kb chaxamycin biosynthesis gene cluster, which was achieved by both mutational analysis in the natural producer and heterologous expression in Streptomyces coelicolor A3(2) strain M1152. Restoration of chaxamycin production in a nonproducing ΔcxmK mutant (cxmK encodes 3-amino-5-hydroxybenzoic acid [AHBA] synthase) was achieved by supplementing the growth medium with AHBA, suggesting that mutasynthesis may be a viable approach for the generation of novel chaxamycin derivatives. 相似文献
4.
《Bioscience, biotechnology, and biochemistry》2013,77(12):2283-2287
A biosynthetic gene cluster of siderophore consisting of five open reading frames (ORFs) was cloned by functional screening of a metagenomic library constructed from tidal-flat sediment. Expression of the cloned biosynthetic genes in Escherichia coli led to the production of vibrioferrin, a siderophore originally reported for the marine bacterium Vibrio parahaemolyticus. To the best of our knowledge, this is the first example of heterologous production of a siderophore by biosynthetic genes cloned from a metagenomic library. The cloned cluster was one of the largest of the clusters obtained by functional screening. In this study, we demonstrated and extended the possibility of function-based metagenomic research. 相似文献
5.
Soo-Keun Choi Soo-Young Park Rumi Kim Seong-Bin Kim Choong-Hwan Lee Jihyun F. Kim Seung-Hwan Park 《Journal of bacteriology》2009,191(10):3350-3358
Polymyxin, a long-known peptide antibiotic, has recently been reintroduced in clinical practice because it is sometimes the only available antibiotic for the treatment of multidrug-resistant gram-negative pathogenic bacteria. Lack of information on the biosynthetic genes of polymyxin, however, has limited the study of structure-function relationships and the development of improved polymyxins. During whole genome sequencing of Paenibacillus polymyxa E681, a plant growth-promoting rhizobacterium, we identified a gene cluster encoding polymyxin synthetase. Here, we report the complete sequence of the gene cluster and its function in polymyxin biosynthesis. The gene cluster spanning the 40.6-kb region consists of five open reading frames, designated pmxA, pmxB, pmxC, pmxD, and pmxE. The pmxC and pmxD genes are similar to genes that encode transport proteins, while pmxA, pmxB, and pmxE encode polymyxin synthetases. The insertional disruption of pmxE led to a loss of the ability to produce polymyxin. Introduction of the pmx gene cluster into the amyE locus of the Bacillus subtilis chromosome resulted in the production of polymyxin in the presence of extracellularly added l-2,4-diaminobutyric acid. Taken together, our findings demonstrate that the pmx gene cluster is responsible for polymyxin biosynthesis.Since polymyxin was first isolated from Bacillus polymyxa in 1947 (1, 4, 47), at least 15 unique polymyxins have been reported (31, 49). Because of its excellent bactericidal activity against gram-negative bacteria, polymyxin antibiotics (polymyxin B and polymyxin E) were used until early 1970 as therapies against many diseases caused by pathogenic microorganisms. However, because they carried serious side effects, including fever, skin eruption, and pain, and also induced severe nephrotoxicity and neurotoxicity (18, 37), it was rapidly replaced by other, better-tolerated antibiotics. In recent years, its application has been restricted to use as an ointment on local surface wounds.Due to the increased and often unnecessary use of antibiotics, pathogenic microorganisms with resistance to antibiotics have become more widespread (2, 14, 30, 38). Under the limited therapeutic options available to treat multidrug-resistant gram-negative bacteria such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, polymyxins are sometimes the only available active antibiotics and have now become important therapeutic agents (13, 25, 28, 29, 55). Many recent reports have shown that patients infected with multidrug-resistant gram-negative pathogens improved upon treatment with polymyxins (19, 27, 44, 48). In addition, polymyxins have been applied to prevent septic shock by removing circulating endotoxin to polystyrene fibers in an immobilized form (8). Therefore, the clinical value of polymyxin, an antibiotic discovered 6 decades ago, is currently being reappraised. However, until now, we have had a very limited understanding of various characteristics of this agent, especially its biosynthetic genes.To analyze structure-function relationships and to develop improved polymyxins with lowered toxicities, novel polymyxin derivatives must be generated. Recently, total or semisynthesis or modifications of polymyxins was performed chemically or enzymatically, and the resulting products were effectively used for structure-function study (6, 20, 36, 45, 50, 52). There is a limitation to obtaining diverse derivatives by using chemical or enzymatic approaches, however, and this limitation is related to the structural complexity of polymyxin. The basic structure of polymyxin is a cyclic heptapeptide with a tripeptide side chain acylated by a fatty acid at the amino terminus (49). Normally, 6-methyloctanoic acid or 6-methylheptanoic acid is attached to the side chain. This structure favors solubility of polymyxin in both water and organic solvent. Unlike other general ribosomally translated peptides, polymyxin is produced by a nonribosomal peptide synthetase (NRPS) (22, 31). NRPSs are multienzyme complexes that have modular structures (35, 46). A module is a distinct section of the multienzyme that is responsible for the incorporation of one or more specific amino acids into the final product. Each module can be divided into different domains, each of which is responsible for a specific biochemical reaction. Three types of domains, the adenylation (A), thiolation (T; also referred to as the peptidyl carrier protein, PCP), and condensation (C) domains, are essential for nonribosomal peptide synthesis. The A-domain plays a role in the selection and activation of an amino acid monomer, the T-domain is responsible for transportation of substrates and elongation intermediates to the catalytic centers, and the C-domain catalyzes peptide bond formation. In addition to these core domains, there are the thioesterase domain (TE-domain), the epimerization domain (E-domain), and some other modification domains. Many NRPS gene clusters have been reported, but no polymyxin biosynthetic gene cluster has been reported to date.During whole genome sequencing of Paenibacillus polymyxa E681, a plant growth-promoting rhizobacterium, we found a gene cluster encoding polymyxin synthetase. In this study, the complete sequences of the polymyxin synthetase genes and the function of the gene cluster have been identified and analyzed by domain analysis, insertional mutagenesis, and heterologous expression of the genes, as well as by antibacterial assay and liquid chromatography-mass spectrometry (LC/MS) analysis of the strains and their culture supernatants. The genome information and the heterologous expression of the polymyxin synthetase gene cluster will be useful for further studies of the regulation of pmx genes, their structure-function relationships, and the improvement of polymyxins. 相似文献
6.
Peng Yeong Woon Kazutoyo Osoegawa Pamela J. Kaisaki Baohui Zhao Joseph J. Catanese Dominique Gauguier Roger Cox Elaine R. Levy G.Mark Lathrop Anthony P. Monaco Pieter J. de Jong 《Genomics》1998,50(3):306
A rat PAC library was constructed in the vector pPAC4 from genomic DNA isolated from female Brown Norway rats. This library consists of 215,409 clones arrayed in 614 384-well microtiter plates. An average insert size of 143 kb was estimated from 217 randomly isolated clones, thus representing approximately 10-fold genome coverage. This coverage provides a very high probability that the library contains a unique sequence in genome screening. Tests on randomly selected clones demonstrated that they are very stable, with only 4 of 130 clones showing restriction digest fragment alterations after 80 generations of serial growth. FISH analysis using 70 randomly chosen PACs revealed no significant chimeric clones. About 7% of the clones analyzed contained repetitive sequences related to centromeric regions that hybridized to some but not all centromeres. DNA plate pools and superpools were made, and high-density filters each containing an array of 8 plates in duplicate were prepared. Library screening on these superpools and appropriate filters with 10 single-locus rat markers revealed an average of 8 positive clones, in agreement with the estimated high genomic coverage of this library and representation of the rat genome. This library provides a new resource for rat genome analysis, in particular the identification of genes involved in models of multifactorial disease. The library and high-density filters are currently available to the scientific community. 相似文献
7.
Florian Schauwecker Frank Pfennig Werner Schr?der Ullrich Keller 《Journal of bacteriology》1998,180(9):2468-2474
The actinomycin synthetases ACMS I, II, and III catalyze the assembly of the acyl peptide lactone precursor of actinomycin by a nonribosomal mechanism. We have cloned the genes of ACMS I (acmA) and ACMS II (acmB) by hybridization screening of a cosmid library of Streptomyces chrysomallus DNA with synthetic oligonucleotides derived from peptide sequences of the two enzymes. Their genes were found to be closely linked and are arranged in opposite orientations. Hybridization mapping and partial sequence analyses indicate that the gene of an additional peptide synthetase, most likely the gene of ACMS III (acmC), is located immediately downstream of acmB in the same orientation. The protein sequence of ACMS II, deduced from acmB, shows that the enzyme contains two amino acid activation domains, which are characteristic of peptide synthetases, and an additional epimerization domain. Heterologous expression of acmB from the mel promoter of plasmid PIJ702 in Streptomyces lividans yielded a functional 280-kDa peptide synthetase which activates threonine and valine as enzyme-bound thioesters. It also catalyzes the dipeptide formation of threonyl–l-valine, which is epimerized to threonyl–d-valine. Both of these dipeptides are enzyme bound as thioesters. This catalytic activity is identical to the in vitro activity of ACMS II from S. chrysomallus.The actinomycins are a class of chromopeptide lactones produced by various Streptomyces strains. They contain two pentapeptide lactone rings attached to chromophoric 4,6-dimethylphenoxazinone-1,9-dicarboxylic acid (actinocin) in an amide-like fashion. Actinocin is formally derived from the compound 4-methyl-3-hydroxyanthranilic acid (4-MHA), but actually the bicyclic actinomycins arise from the oxidative condensation of two preformed monocyclic 4-MHA pentapeptide lactones (12). Previous investigations have revealed that the formation of the 4-MHA pentapeptide lactones is catalyzed by three actinomycin synthetases (ACMS I, II, and III) (13, 15). ACMS I (45 kDa) is a 4-MHA–AMP ligase which activates 4-MHA as adenylate. The five amino acids of the pentapeptide lactone ring of actinomycin (NH2-cyclo[Thr–d-Val–Pro–N-methyl-Gly–N-methyl-Val] for actinomycin D) are assembled by ACMS II (280 kDa) and ACMS III (480 kDa) which from their properties belong to the class of peptide synthetases (13, 26, 27). ACMS II catalyzes the activation of threonine and valine. In the presence of ACMS I, which supplies 4-MHA–adenylate, 4-MHA–threonine and 4-MHA–threonyl–d-valine (via 4-MHA–threonyl–l-valine) are formed on the surface of ACMS II. In the absence of 4-MHA or ACMS I, purified ACMS II can synthesize both threonyl–l-valine and threonyl–d-valine, though to a lesser extent than the corresponding 4-MHA dipeptides can. The epimerization of valine is catalyzed by ACMS II at the acyl-dipeptide stage. An analysis of ACMS III suggests that it elongates the 4-MHA–Thr–d-Val dipeptide by successive incorporation of proline, N-methylglycine (sarcosine), and N-methyl-l-valine into the growing peptide chain (13). N-methylation is an additional feature of ACMS III. A total cell-free system for 4-MHA pentapeptide lactone synthesis is not available yet. Thus, it is not known how 4-MHA dipeptide transfer from ACMS II to ACMS III is accomplished, nor is the mechanism of lactone formation and release from the 4-MHA pentapeptide known.The available data indicate that ACMS II and ACMS III contain two- and three-amino-acid activation domains, respectively. It is known that activation domains of peptide synthetases are highly conserved in their sequences and are composed of a segment for amino acid adenylation and a segment for binding the activated amino acid as a thioester (17, 24, 25, 32). Thioester formation occurs via the thiol group of 4′-phosphopantetheine, which is a covalently bound cofactor of the activation domain. ACMS II and III both contain 4′-phosphopantetheine. In contrast, ACMS I has no 4′-phosphopantetheine cofactor, consistent with the finding that it does not form a thioester with 4-MHA. Data from previous work pointed instead to the formation of a 4-MHA thioester with ACMS II (26). In order to investigate the modular structure of the ACMSs and the reaction mechanisms in more detail, we set out to clone the ACMS genes from Streptomyces chrysomallus with oligonucleotide probes derived from partial sequences of ACMS I and II. We show that the genes of ACMS I and II and of a third peptide synthetase, most probably the gene of ACMS III (acmA, acmB, and acmC, respectively) are closely linked, forming a gene cluster. A total sequence determination of acmB and the characterization of the heterologously expressed functional active gene product confirm the significance of this peptide synthetase gene cluster. 相似文献
8.
Ajit Prakash Sreekanth Rajan Ho Sup Yoon 《Protein science : a publication of the Protein Society》2016,25(4):905-910
Human FKBP25 (hFKBP25) is a nuclear immunophilin and interacts with several nuclear proteins, hence involving in many nuclear events. Similar to other FKBPs, FK506 binding domain (FKBD) of hFKBP25 also binds to immunosuppressive drugs such as rapamycin and FK506, albeit with a lower affinity for the latter. The molecular basis underlying this difference in affinity could not be addressed due to the lack of the crystal structure of hFKBD25 in complex with FK506. Here, we report the crystal structure of hFKBD25 in complex with FK506 determined at 1.8 Å resolution and its comparison with the hFKBD25–rapamycin complex, bringing out the microheterogeneity in the mode of interaction of these drugs, which could possibly explain the lower affinity for FK506. 相似文献
9.
PvFKBP35 is a member of the FK506 binding protein family (FKBP) from Plasmodium vivax. The FK506-binding domain of PvFKBP35 shows a canonical peptidylprolyl cis–trans isomerase (PPIase) activity. To understand the role of PvFKBP35 in the parasite, we have performed NMR studies. Here, we
report the assignment of the FK506-binding domain of PvFKBP35. 相似文献
10.
Reconstitution of the Myxothiazol Biosynthetic Gene Cluster by Red/ET Recombination and Heterologous Expression in Myxococcus xanthus
下载免费PDF全文
![点击此处可从《Applied microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Olena Perlova Jun Fu Silvia Kuhlmann Daniel Krug A. Francis Stewart Youming Zhang Rolf Müller 《Applied microbiology》2006,72(12):7485-7494
Although many secondary metabolites exhibiting important pharmaceutical and agrochemical activities have been isolated from myxobacteria, most of these microorganisms remain difficult to handle genetically. To utilize their metabolic potential, heterologous expression methodologies are currently being developed. Here, the Red/ET recombination technology was used to perform all required gene cluster engineering steps in Escherichia coli prior to the transfer into the chromosome of the heterologous host. We describe the integration of the complete 57-kbp myxothiazol biosynthetic gene cluster reconstituted from two cosmids from a cosmid library of the myxobacterium Stigmatella aurantiaca DW4-3/1 into the chromosome of the thus far best-characterized myxobacterium, Myxococcus xanthus, in one step. The successful integration and expression of the myxothiazol biosynthetic genes in M. xanthus results in the production of myxothiazol in yields comparable to the natural producer strain. 相似文献
11.
The emergence of multi-drug-resistant strains of Plasmodium parasites has prompted the search for alternative therapeutic strategies for combating malaria. One possible strategy is to exploit existing drugs as lead compounds. FK506 is currently used in the clinic for preventing transplant rejection. It binds to a alpha/beta protein module of approximately 120 amino acids known as the FK506 binding domain (FKBD), which is found in various organisms, including human, yeast, and Plasmodium falciparum (PfFKBD). Antiparasitic effects of FK506 and its analogues devoid of immunosuppressive activities have been demonstrated. We report here the crystallographic structure at 2.35 A resolution of PfFKBD complexed with FK506. Compared to the human FKBP12-FK506 complex reported earlier, the structure reveals structural differences in the beta5-beta6 segment that lines the FK506 binding site. The presence in PfFKBD of Cys-106 and Ser-109 (substituting for His-87 and Ile-90, respectively, in human FKBP12), which are 4-5 A from the nearest atom of the FK506 compound, suggests possible routes for the rational design of analogues of FK506 with specific antiparasitic activity. Upon ligand binding, several conformational changes occur in PfFKBD, including aromatic residues that shape the FK506 binding pocket as shown by NMR studies. A microarray analysis suggests that FK506 and cyclosporine A (CsA) might inhibit parasite development by interfering with the same signaling pathways. 相似文献
12.
13.
植物细胞色素P450基因的异源表达系统研究进展 总被引:6,自引:1,他引:5
细胞色素P450氧化酶是一类具有多种催化功能含血红素的氧化酶系。由于参与多种类型的氧化反应,在植物生命活动中有重要功能,其研究一直受到重视。自1990年第一个植物P450基因成功克隆以来,到2002年年底,已有600多个P450基因被克隆,有100多个基因在细菌、酵母、杆状病毒昆虫细胞等异源表达系统中成功表达并鉴定了功能。拟对植物P450的大肠杆菌、酵母、杆状病毒昆虫细胞表达系统的特点进行比较,对在各表达系统中成功表达并进行了功能鉴定的植物P450进行归纳,并对目前植物P450异源表达的现状和应用进行概述。 相似文献
14.
Isolation, Characterization, and Heterologous Expression of the Novel Lantibiotic Epicidin 280 and Analysis of Its Biosynthetic Gene Cluster 总被引:7,自引:5,他引:2
下载免费PDF全文
![点击此处可从《Applied microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Christoph Heidrich Ulrike Pag Michaele Josten Jrg Metzger Ralph W. Jack Gabriele Bierbaum Günther Jung Hans-Georg Sahl 《Applied microbiology》1998,64(9):3140-3146
Epicidin 280 is a novel type A lantibiotic produced by Staphylococcus epidermidis BN 280. During C18 reverse-phase high-performance liquid chromatography two epicidin 280 peaks were obtained; the two compounds had molecular masses of 3,133 ± 1.5 and 3,136 ± 1.5 Da, comparable antibiotic activities, and identical amino acid compositions. Amino acid sequence analysis revealed that epicidin 280 exhibits 75% similarity to Pep5. The strains that produce epicidin 280 and Pep5 exhibit cross-immunity, indicating that the immunity peptides cross-function in antagonization of both lantibiotics. The complete epicidin 280 gene cluster was cloned and was found to comprise at least five open reading frames (eciI, eciA, eciP, eciB, and eciC, in that order). The proteins encoded by these open reading frames exhibit significant sequence similarity to the biosynthetic proteins of the Pep5 operon of Staphylococcus epidermidis 5. A gene for an ABC transporter, which is present in the Pep5 gene cluster but is necessary only for high yields (G. Bierbaum, M. Reis, C. Szekat, and H.-G. Sahl, Appl. Environ. Microbiol. 60:4332–4338, 1994), was not detected. Instead, upstream of the immunity gene eciI we found an open reading frame, eciO, which could code for a novel lantibiotic modification enzyme involved in reduction of an N-terminally located oxopropionyl residue. Epicidin 280 produced by the heterologous host Staphylococcus carnosus TM 300 after introduction of eciIAPBC (i.e., no eciO was present) behaved homogeneously during reverse-phase chromatography. 相似文献
16.
Heterologous Expression of Novobiocin and Clorobiocin Biosynthetic Gene Clusters 总被引:7,自引:0,他引:7
下载免费PDF全文
![点击此处可从《Applied microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Alessandra S. Eustáquio Bertolt Gust Ute Galm Shu-Ming Li Keith F. Chater Lutz Heide 《Applied microbiology》2005,71(5):2452-2459
A method was developed for the heterologous expression of biosynthetic gene clusters in different Streptomyces strains and for the modification of these clusters by single or multiple gene replacements or gene deletions with unprecedented speed and versatility. λ-Red-mediated homologous recombination was used for genetic modification of the gene clusters, and the attachment site and integrase of phage C31 were employed for the integration of these clusters into the heterologous hosts. This method was used to express the gene clusters of the aminocoumarin antibiotics novobiocin and clorobiocin in the well-studied strains Streptomyces coelicolor and Streptomyces lividans, which, in contrast to the natural producers, can be easily genetically manipulated. S. coelicolor M512 derivatives produced the respective antibiotic in yields comparable to those of natural producer strains, whereas S. lividans TK24 derivatives were at least five times less productive. This method could also be used to carry out functional investigations. Shortening of the cosmids' inserts showed which genes are essential for antibiotic production. 相似文献
17.
巴斯德毕赤酵母表达系统在外源基因表达中的研究进展 总被引:7,自引:0,他引:7
巴斯德毕赤酵母是目前应用最广泛的外源蛋白表达系统。分别从的菌株、载体、外源基因整合、表达产物糖基化和外源基因高效表达等方面综述了毕赤酵母表达系统的研究进展。 相似文献
18.
禽流感病毒NP蛋白与T4噬菌体SOC蛋白的融合表达 总被引:1,自引:0,他引:1
利用PCR技术扩增禽流感病毒(avian influenza virus,AIV)NP基因。将NP基因克隆至T4噬菌体表达质粒pSOC的SOC基因(T4噬菌体表面非结构蛋白基因)下游,构建成T4噬菌体SOC位点表达NP的表达载体pSOC-NP。将其转化至大肠杆菌BL21(DE3),经IPTG诱导后表达的目的蛋白SOC-NP进行SDS-PAGE与Western-blot方法检测。结果表明,表达的SOC-NP蛋白相对分子质量约58kD,表达量占菌体总蛋白量的20.34%,并具有与AIV特异性抗体反应的活性。 相似文献
19.
《The Journal of biological chemistry》2010,285(19):14292-14300
20.
Controlled Expression in Klebsiella pneumoniae and Shigella flexneri Using a Bacteriophage P1-Derived C1-Regulated Promoter System
下载免费PDF全文
![点击此处可从《Journal of bacteriology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
David A. Schofield Caroline Westwater Joseph W. Dolan Michael G. Schmidt James S. Norris 《Journal of bacteriology》2001,183(23):6947-6950
The utility of promoters regulated by the bacteriophage P1 temperature-sensitive C1 repressor was examined in Shigella flexneri and Klebsiella pneumoniae. Promoters carrying C1 operator sites driving LacZ expression had induction/repression ratios of up to 240-fold in S. flexneri and up to 50-fold in K. pneumoniae. The promoters exhibited remarkably low basal expression, demonstrated modulation by temperature, and showed rapid induction. This system will provide a new opportunity for controlled gene expression in enteric gram-negative bacteria. 相似文献